Literature DB >> 6783223

Pseudomembranous colitis after treatment with metronidazole.

G Thomson, A H Clark, K Hare, W G Spilg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783223      PMCID: PMC1504673          DOI: 10.1136/bmj.282.6267.864-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery.

Authors:  M R Keighley; Y Arabi; J Alexander-Williams; D Youngs; D W Burdon
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

2.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

  3 in total
  8 in total

1.  Clostridium difficile colitis in children with cystic fibrosis.

Authors:  Sunny Zaheed Hussain; Cathy Chu; David P Greenberg; David Orenstein; Seema Khan
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

2.  Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli.

Authors:  C M Hunt; J A Harvey; E R Youngs; S T Irwin; T M Reid
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

Review 3.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Non-Clostridium difficile pseudomembranous colitis responding to both vancomycin and metronidazole. ?

Authors:  R K Phillips; G Glazer; S P Borriello
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

Review 5.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 6.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

7.  Antibiotic-associated colitis and cystic fibrosis.

Authors:  C S Pokorny; P T Bye; C MacLeod; W S Selby
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

8.  Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.

Authors:  W L George; R D Rolfe; G K Harding; R Klein; C W Putnam; S M Finegold
Journal:  Infection       Date:  1982       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.